ORPHA:676
Autosomal dominant hereditary chronic pancreatitis
Publications
47,878
99th percentile
Trials
2
Interventional, condition-specific
Researchers
1,225
Distinct authors in sample
Gene link
CFTR, CLDN2, CPA1
Definitive
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare gastroenterologic disease characterized by recurrent acute pancreatitis and/or chronic pancreatitis in at least 2 first-degree relatives, or 3 or more second-degree relatives in 2 or more generations, for which no predisposing factors are identified. This rare inherited form of pancreatitis leads to irreversible damage to both exocrine and endocrine components of the pancreas.
How rare: 1-9 / 1 000 000 — roughly one to nine people per million. In a city the size of Kolkata, perhaps a few dozen.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008185
- MeSH:C537262
- OMIM:167800
- UMLS:C0238339
- NCIT:C95436
Additional Mondo synonyms (2)
hereditary chronic pancreatitis · hereditary pancreatitis
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — CFTR, CLDN2, CPA1, CTRC, PRSS1…
- LiteraturePresent
47,878 matched papers (26,294 in last 10 years) Source
- Phenotype characterisedPresent
35 HPO annotations (e.g. Increased total leukocyte count; Abnormal circulating enzyme concentration or activity; Jaundice) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CFTR, CLDN2, CPA1…).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
35
Associated phenotypes · MONDO:0008185
- Increased total leukocyte count
- Abnormal circulating enzyme concentration or activity
- Jaundice
- Pancreatic calcification
- Malnutrition
Showing 5 of 35 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
47,878
47,878 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
47,878 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
26,294 in the last 10 years · high confidence · 99th percentile (publications denominator)
Phrase hits: 2,524 · MeSH hits: 0
Who's working on it?
1,225
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Sahin-Tóth M10 papers · 2026
Department of Surgery, University of California Los Angeles, Los Angeles, California.
Papers in Europe PMC - 02Masamune A6 papers · 2026
Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Papers in Europe PMC - 03Wu D5 papers · 2026
Adelaide Medical School, University of Adelaide, Adelaide, SA.
Papers in Europe PMC - 04Coates PT4 papers · 2026
Adelaide Medical School, University of Adelaide, Adelaide, SA.
Papers in Europe PMC - 05Demcsák A4 papers · 2025
Department of Surgery, University of California Los Angeles, Los Angeles, California, USA.
Papers in Europe PMC - 06Abu-El-Haija M3 papers · 2026
Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Papers in Europe PMC - 07Buscail L3 papers · 2026
Department of Gastroenterology and Pancreatology, CHU Toulouse-Rangueil, University Hospital Centre, Toulouse University, UPS, 31059 Toulouse, France.
Papers in Europe PMC - 08Chen JM3 papers · 2026
Univ Brest, Inserm, EFS, UMR 1078, GGB, F-29200, Brest, France. Electronic address: jian-min.chen@univ-brest.fr.
Papers in Europe PMC - 09Drogemuller CJ3 papers · 2026
Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Papers in Europe PMC - 10Hamada S3 papers · 2026
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; none in our sample are currently recruiting. 134 trials are registered for chronic pancreatitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 28 July 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
high confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Broader category: chronic pancreatitis
134
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT04996628·RECRUITING·Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis · Chronic Pain·Matched via name phrase
- NCT03434392·RECRUITING·QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
Not reviewed·Conditions: Chronic Pancreatitis · Chronic Pain·Matched via name phrase
- NCT05664880·RECRUITING·A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
Not reviewed·Conditions: Chronic Pancreatitis·Matched via name phrase
- NCT07109180·RECRUITING·Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)
Not reviewed·Conditions: Chronic Pancreatitis · Surgery · Minimally Invasive Surgical Technique · Robot Surgica·Matched via name phrase
- NCT04654377·NOT YET RECRUITING·Personalized Education and Pain Response in Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis · Pain Syndrome · Depression, Anxiety·Matched via name phrase
- NCT07697352·NOT YET RECRUITING·Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis
Not reviewed·Conditions: Pancreatitis, Chronic · Exocrine Pancreatic Insufficiency (EPI)·Matched via name phrase
- NCT06585735·NOT YET RECRUITING·Proteolytic Enzyme Fortified Protein Supplement in Chronic Pancreatitis.
Not reviewed·Conditions: Chronic Pancreatitis · Malnutrition·Matched via name phrase
- NCT06178315·RECRUITING·EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis·Matched via name phrase
- NCT07314489·RECRUITING·A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose·Matched via name phrase
- NCT06655051·RECRUITING·Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis · Benign Biliary Stricture·Matched via name phrase
- NCT07074379·RECRUITING·Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
Not reviewed·Conditions: Painless Chronic Pancreatitis·Matched via name phrase
- NCT07418593·RECRUITING·Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis · Recurrent Acute Pancreatitis · Exocrine Pancreatic Insufficiency·Matched via name phrase
- NCT06205342·RECRUITING·Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
Not reviewed·Conditions: Chronic Pancreatitis · Chronic Pain·Matched via name phrase
- NCT06386224·RECRUITING·Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
Not reviewed·Conditions: Pancreatitis · Chronic Pancreatitis · Acute Recurrent Pancreatitis·Matched via name phrase
- NCT06362187·NOT YET RECRUITING·VR Pilot for Pancreatitis
Not reviewed·Conditions: Chronic Pancreatitis · Recurrent Pancreatitis·Matched via name phrase
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07413029·RECRUITING·French National Cohort of Patients With PRSS1 Mutations
Not reviewed·Conditions: Hereditary Pancreatitis · PRSS1 Gene Mutation·Matched via name phrase
- NCT00830557·RECRUITING·Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Not reviewed·Conditions: Islet Cell Tumor · Pancreatic Cancer · Pancreatic Disease · Acute Pancreatitis·Matched via name phrase
- NCT04743479·RECRUITING·Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Not reviewed·Conditions: Pancreatic Cancer · Diabetes · Familial Pancreatic Cancer · Pancreatic Cystic Neoplasm·Matched via name phrase
- NCT07700992·RECRUITING·A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
Not reviewed·Conditions: Familial Pancreatic Cancer · Familial Pancreatic Carcinoma · Hereditary Pancreatic Cancer · Hereditary Pancreatitis·Matched via name phrase
- NCT04095195·RECRUITING·Registry of Subjects at Risk of Pancreatic Cancer
Not reviewed·Conditions: Familial Pancreatic Cancer · BRCA1 Mutation · BRCA2 Mutation · Lynch Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 15 · after dedupe 15 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 15 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (15)
- isrctn·ISRCTN62546421·Recruiting·The European registry of familial pancreatic cancer and hereditary pancreatitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79479093·Recruiting·Hereditary pancreatic cancer early surveillance program
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17524311·Recruiting·Prevent from home: young person and buddies’ cardiovascular health improvement feasibility study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18135766·No longer recruiting·Evaluation of controlling high blood pressure using a combined amlodipine and perindopril arginine approach in Morocco
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN73786674·No longer recruiting·Exploring the use of a digitally delivered low calorie diet and behaviour change programme on inducing diabetes remission in patients with type 2 diabetes.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12809537·No longer recruiting·Phase I study to evaluate the safety of crovalimab, the effects of crovalimab on the body, and the processing of crovalimab in participants with lupus nephritis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11459997·No longer recruiting·Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN41530928·Suspended·Comparing three early treatments for sudden-onset pancreatitis (inflammation of the pancreas) caused by high levels of fat in the blood
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15073006·No longer recruiting·Lowering Events in Non-proliferative retinopathy in Scotland
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17837384·No longer recruiting·Postprandial effects of genetic variation on carbohydrate digestion
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65689096·No longer recruiting·Comparison of two techniques for collecting umbilical cord blood: on the mother (upper level) versus on the delivery table (bottom level)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN44912429·No longer recruiting·Double blind randomised controlled trial to investigate the efficacy of ANTOX (version 1.2) and MGCT (Magnesium) for the treatment of hereditary and idiopathic chronic pancreatitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN73258526·No longer recruiting·Effect of omeprazole or resveratrol on iron status in thalassemia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14265371·No longer recruiting·A trial to determine bexarotene's safety and tolerability and its ability to promote brain repair in patients with multiple sclerosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN51822988·No longer recruiting·A double-blind placebo-controlled study on the effect of cerivastatin on the process of atherosclerosis in non-insulin-dependent diabetes mellitus
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Autosomal dominant hereditary chronic pancreatitis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Autosomal dominant hereditary chronic pancreatitis" OR "hereditary chronic pancreatitis" OR "hereditary pancreatitis") OR ("CFTR" OR "CFTR syndrome" OR "CFTR-related" OR "CLDN2" OR "CLDN2 syndrome" OR "CLDN2-related" OR "CPA1" OR "CPA1 syndrome" OR "CPA1-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Autosomal dominant hereditary chronic pancreatitis" OR "hereditary chronic pancreatitis" OR "hereditary pancreatitis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"chronic pancreatitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T14:53:37.066Z
